Cite
HARVARD Citation
Klimek, V. et al. (n.d.). Phase 2 Study of Selinexor in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents: Interim Report. Leukemia research. pp. S32-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Klimek, V. et al. (n.d.). Phase 2 Study of Selinexor in Patients with Myelodysplastic Syndromes Refractory to Hypomethylating Agents: Interim Report. Leukemia research. pp. S32-. [Online].